Psoriasis and sleep problems study
Part of Mental health, Skin clinical trials.
This study explores how moderate-to-severe psoriasis affects sleep. It may help doctors understand and improve sleep problems in people with psoriasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psoriasis by a doctor.
- Your psoriasis is moderate to severe (covering more than 10% of your body).
- You do not have a diagnosed sleep disorder (like sleep apnea or restless legs).
- You are not taking sleeping pills or sedatives regularly.
- You do not have diabetes or serious heart, liver, or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called HSK44459 for people with moderate to severe plaque psoriasis who need systemic therapy (medicine that works throughout the body). The goal is to see if it is safe and effective.
This study tests a new oral medication (HS-20118) for safety and how it works in the body. It is for healthy volunteers or people with chronic plaque psoriasis, and will help see if the drug is safe and how it behaves with or without food.
This study looks at immune system differences in people with moderate-to-severe psoriasis. It aims to help guide more precise (targeted) treatment choices and may improve how well treatment works for you.
This study looks at sleep problems in people with psoriatic arthritis or SAPHO syndrome. Participants will stay in the hospital for special sleep tests to understand their sleep issues better.
This study looks at health problems like heart disease and arthritis that are common in people with psoriasis. It aims to better understand these connections to improve care.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
Hear when a new Moderate-to-severe Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.